|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
18.220 +0.110 (+0.607%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 1,696,211 | 45.176% | 1,168,384 | 786,056 | 669,703 | 946,049 |
| Cost of Sales | (416,780) | 70.561% | (244,359) | (210,801) | (288,513) | (320,472) |
| Gross Profit | 1,279,431 | 38.463% | 924,025 | 575,255 | 381,190 | 625,577 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (4,110) | -- | 2,361 | 10,416 | (1,122) | 41 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (43,205) | 71.387% | (25,209) | (28,225) | (32,306) | (28,249) | |
| Profit / (Loss) before Taxation | (29,542) | -93.921% | (485,947) | (684,894) | (1,175,833) | (988,912) | |
| Taxation | (7,444) | -- | 19,538 | (3,551) | 50,495 | (9,448) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 62,487 | 17.949% | 52,978 | 42,754 | 128,917 | 87,031 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 25,501 | -- | (413,431) | (645,691) | (996,421) | (911,329) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 57,248 | 47.943% | 38,696 | (61) | (40,479) | (13,209) |
| Depreciation & Amortisation | 157,637 | -3.472% | 163,307 | -- | -- | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 2.000 | -- | -42.000 | -66.000 | -101.000 | -100.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 5.809 | -- | 6.229 | 6.591 | 8.635 | 7.846 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 25,501 |
| %Change | -- |
| EPS / (LPS) | RMB 0.020 |
| NBV Per Share (¥) | RMB 5.809 |